Clinical Trial: Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence
Study Status: Completed
Recruit Status: Completed
Condition:
Cardiovascular Diseases
Acute Coronary Syndrome
Study Type: Interventional
Official Title: Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence: A Parallel Single-blinded Randomized Trial
Brief Summary:
This is a pilot study that was conducted to prove the efficacy and safety of ticagrelor generically named Ticaloguard® compared to its brand Brilique® in healthy volunteers. we advocate comparing the clinical efficacy rather than simple bioequivalence comparison.
Read more